In previous studies, we identified several enriched and depleted KEGG signaling pathways in a model of secondary dasatinib resistance in a distinct subtype of BCP-ALL, i.e., pre-BCR+/E2A-PBX1+, using gene ontology (GO) analysis [12]. The gene discussed is PBX1; the disease is acute lymphoblastic leukemia.